Figure 8.

Immune landscape of risk score in the TCGA cohort. (A) Correlations between risk score, levels of expression of PD-L1, CYT, TBK1, IRF3, MB21D1, CTLA-4, PD-1, and TMEM173, immune score, stromal score, ESTINATE score, and tumor purity in the TCGA cohort. (B) Volcano plots for immune cell sub-population enrichment in high- and low-risk patients according to NES scores from ssGSEA. (C) Gene set enrichment analyses described the MeSH terms correlated with risk score using gendoo term in the TCGA cohort. (D) Gene set enrichment analysis described the MeSH terms correlated with the risk score using gene2pubmed term in the TCGA cohort.